Skip to main content

Table 5 QoL scores at baseline, 3, 6, 12 and 96 months for the experimental and the control group

From: Naprapathy versus orthopaedic standard care for common musculoskeletal disorders: an 8-year follow-up of a pragmatic randomized controlled trial in Sweden

Group Month Sum Number of participants Mean value/participant with 95% CI
Control group 0 26.108 38 0.687 (0.636–0.738)
  3 26.417 38 0.695 (0.647–0.743)
  6 27.532 38 0.725 (0.675–0.774)
  12 26.909 37 0.727 (0.675–0.779)
  96 26.372 37 0.713 (0.668–0.758)
Experimental group 0 26.225 40 0.656 (0.620–0.691)
  3 29.490 40 0.737 (0.694–0.780)
  6 30.154 40 0.754 (0.707–0.800)
  12 29.282 38 0.771 (0.722–0.819)
  96 31.288 38 0.823 (0.785–0.862)
  1. Confidence intervals 95%, p-values < 0.01
  2. The maximum, most preferrable score of QoL is 1.0